Skip to main content
CERS
NASDAQ Life Sciences

Cerus Secures $110M Debt Facility, Expects to Cut Annual Interest Costs by $3.5M

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.71
Mkt Cap
$543M
52W Low
$1.15
52W High
$3.15
52W Position info
136% above low
Off High info
14% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CERS has more than doubled off its 52-week low of $1.15.

Summary

Cerus Corporation has closed a new debt facility of up to $110 million, comprising a 5-year term loan and an asset-backed revolving loan. This financing is expected to reduce the company's annual cash interest expense by up to $3.5 million. The move provides significant liquidity and financial flexibility, especially following the Q1 2026 report which noted increased operating cash burn and commencing debt amortization. This new facility directly addresses those financial pressures, improving the company's balance sheet.

At the time of this announcement, CERS was trading at $2.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $543M. The 52-week trading range was $1.15 to $3.15. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

CERS - Latest Insights

CERS
Jun 08, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.60
Real-time Price: $2.87 info
Change: +$0.270 (+10%) info
Market Cap: $575.059M info
CERS
Jun 03, 2026, 4:17 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.66
Real-time Price: $2.87 info
Change: +$0.210 (+8%) info
Market Cap: $575.059M info
CERS
May 27, 2026, 12:52 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $2.82
Real-time Price: $2.87 info
Change: +$0.050 (+2%) info
Market Cap: $575.059M info
CERS
Apr 30, 2026, 5:05 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.16
Real-time Price: $2.87 info
Change: +$0.710 (+33%) info
Market Cap: $575.059M info
CERS
Apr 30, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.25
Real-time Price: $2.87 info
Change: +$0.620 (+28%) info
Market Cap: $575.059M info